Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Kermeen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Crohn'S & Colitis 360|January 6, 2025
Development and Validation of a Scoring System to Predict 2-Year Clinical Remission in Ulcerative Colitis Patients on VedolizumabThanaboon Chaemsupaphan, Aviv Pudipeddi, Huiyu Lin, et al.
World Journal of Gastroenterology|January 15, 2025
Vedolizumab serum trough concentrations with and without thiopurines in ulcerative colitis: The prospective VIEWS pharmacokinetics studyThanaboon Chaemsupaphan, Aviv Pudipeddi, Hui-Yu Lin, et al.
Gastroenterology|January 28, 2017
Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel DiseasesRupert W Leong, Marie Ooi, Crispin Corte, et al.
Antiviral Therapy|January 23, 2018
Factors associated with non-adherence to HBV antiviral therapySuzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, et al.
Journal of Clinical Nursing|April 1, 2018
Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapySuzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, et al.
Antiviral Therapy|September 16, 2016
Factors associated with HBV virological breakthroughSuzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled TrialAviv Pudipeddi, Sudarshan Paramsothy, Viraj Kariyawasam, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Crohn'S & Colitis 360|January 6, 2025
Development and Validation of a Scoring System to Predict 2-Year Clinical Remission in Ulcerative Colitis Patients on VedolizumabThanaboon Chaemsupaphan, Aviv Pudipeddi, Huiyu Lin, et al.
World Journal of Gastroenterology|January 15, 2025
Vedolizumab serum trough concentrations with and without thiopurines in ulcerative colitis: The prospective VIEWS pharmacokinetics studyThanaboon Chaemsupaphan, Aviv Pudipeddi, Hui-Yu Lin, et al.
Gastroenterology|January 28, 2017
Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel DiseasesRupert W Leong, Marie Ooi, Crispin Corte, et al.
Antiviral Therapy|January 23, 2018
Factors associated with non-adherence to HBV antiviral therapySuzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, et al.
Journal of Clinical Nursing|April 1, 2018
Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapySuzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, et al.
Antiviral Therapy|September 16, 2016
Factors associated with HBV virological breakthroughSuzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled TrialAviv Pudipeddi, Sudarshan Paramsothy, Viraj Kariyawasam, et al.
Pageof 1